Selected research
Market Outlook & Growth Opportunities
Global Life & Health Reinsurance Market Outlook and Growth Opportunities 2026
Market perspective
The global Life & Health Reinsurance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Life & Health Reinsurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Life & Health Reinsurance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Life & Health Reinsurance market include Munich Re, Swiss Re, Hannover Re, SCOR SE, Lloyd’s, Berkshire Hathaway, Great-West Lifeco, RGA and China RE, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Life & Health Reinsurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Life & Health Reinsurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Life & Health Reinsurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life & Health Reinsurance market.
Life & Health Reinsurance Segment by Company
Munich Re
Swiss Re
Hannover Re
SCOR SE
Lloyd’s
Berkshire Hathaway
Great-West Lifeco
RGA
China RE
Korean Re
PartnerRe
GIC Re
Mapfre
Alleghany
Everest Re
Axa
Canada Life Reinsurance
Fairfax
AXIS
CCR Re
Sompo
The Toa Reinsurance Company
Life & Health Reinsurance Segment by Type
Proportional Reinsurance
Non-proportional Reinsurance
Life & Health Reinsurance Segment by Application
Children
Adults
Senior Citizens
Life & Health Reinsurance Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Life & Health Reinsurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Life & Health Reinsurance key companies, revenue, market share, and recent developments.
3. To split the Life & Health Reinsurance breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Life & Health Reinsurance market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Life & Health Reinsurance significant trends, drivers, influence factors in global and regions.
6. To analyze Life & Health Reinsurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life & Health Reinsurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Life & Health Reinsurance and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life & Health Reinsurance.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life & Health Reinsurance industry.
Chapter 3: Detailed analysis of Life & Health Reinsurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Life & Health Reinsurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Life & Health Reinsurance in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Proportional Reinsurance
- Non-proportional Reinsurance
Applications
- Children
- Adults
- Senior Citizens
Companies covered
- Munich Re
- Swiss Re
- Hannover Re
- SCOR SE
- Lloyd’s
- Berkshire Hathaway
- Great-West Lifeco
- RGA
- China RE
- Korean Re
- PartnerRe
- GIC Re
- Mapfre
- Alleghany
- Everest Re
- Axa
- Canada Life Reinsurance
- Fairfax
- AXIS
- CCR Re
- Sompo
- The Toa Reinsurance Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Life & Health Reinsurance Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Life & Health Reinsurance Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Life & Health Reinsurance Market Dynamics
- 2.1 Life & Health Reinsurance Industry Trends
- 2.2 Life & Health Reinsurance Industry Drivers
- 2.3 Life & Health Reinsurance Industry Opportunities and Challenges
- 2.4 Life & Health Reinsurance Industry Restraints
3 Life & Health Reinsurance Market by Company
- 3.1 Global Life & Health Reinsurance Company Revenue Ranking in 2025
- 3.2 Global Life & Health Reinsurance Revenue by Company (2021-2026)
- 3.3 Global Life & Health Reinsurance Company Ranking (2024-2026)
- 3.4 Global Life & Health Reinsurance Company Manufacturing Base and Headquarters
- 3.5 Global Life & Health Reinsurance Company Product Type and Application
- 3.6 Global Life & Health Reinsurance Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Life & Health Reinsurance Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Life & Health Reinsurance Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Life & Health Reinsurance Market by Type
- 4.1 Life & Health Reinsurance Type Introduction
- 4.1.1 Proportional Reinsurance
- 4.1.2 Non-proportional Reinsurance
- 4.2 Global Life & Health Reinsurance Sales Value by Type
- 4.2.1 Global Life & Health Reinsurance Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Life & Health Reinsurance Sales Value by Type (2021-2032)
- 4.2.3 Global Life & Health Reinsurance Sales Value Share by Type (2021-2032)
5 Life & Health Reinsurance Market by Application
- 5.1 Life & Health Reinsurance Application Introduction
- 5.1.1 Children
- 5.1.2 Adults
- 5.1.3 Senior Citizens
- 5.2 Global Life & Health Reinsurance Sales Value by Application
- 5.2.1 Global Life & Health Reinsurance Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Life & Health Reinsurance Sales Value by Application (2021-2032)
- 5.2.3 Global Life & Health Reinsurance Sales Value Share by Application (2021-2032)
6 Life & Health Reinsurance Regional Value Analysis
- 6.1 Global Life & Health Reinsurance Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Life & Health Reinsurance Sales Value by Region (2021-2032)
- 6.2.1 Global Life & Health Reinsurance Sales Value by Region: 2021-2026
- 6.2.2 Global Life & Health Reinsurance Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Life & Health Reinsurance Sales Value (2021-2032)
- 6.3.2 North America Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Life & Health Reinsurance Sales Value (2021-2032)
- 6.4.2 Europe Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Life & Health Reinsurance Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Life & Health Reinsurance Sales Value (2021-2032)
- 6.6.2 South America Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Life & Health Reinsurance Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Life & Health Reinsurance Sales Value Share by Country, 2025 VS 2032
7 Life & Health Reinsurance Country-level Value Analysis
- 7.1 Global Life & Health Reinsurance Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Life & Health Reinsurance Sales Value by Country (2021-2032)
- 7.2.1 Global Life & Health Reinsurance Sales Value by Country (2021-2026)
- 7.2.2 Global Life & Health Reinsurance Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.7.2 France Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.14.2 China Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.17.2 India Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Life & Health Reinsurance Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Life & Health Reinsurance Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Life & Health Reinsurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Munich Re
- 8.1.1 Munich Re Company Information
- 8.1.2 Munich Re Business Overview
- 8.1.3 Munich Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.1.4 Munich Re Life & Health Reinsurance Product Portfolio
- 8.1.5 Munich Re Recent Developments
- 8.2 Swiss Re
- 8.2.1 Swiss Re Company Information
- 8.2.2 Swiss Re Business Overview
- 8.2.3 Swiss Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.2.4 Swiss Re Life & Health Reinsurance Product Portfolio
- 8.2.5 Swiss Re Recent Developments
- 8.3 Hannover Re
- 8.3.1 Hannover Re Company Information
- 8.3.2 Hannover Re Business Overview
- 8.3.3 Hannover Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.3.4 Hannover Re Life & Health Reinsurance Product Portfolio
- 8.3.5 Hannover Re Recent Developments
- 8.4 SCOR SE
- 8.4.1 SCOR SE Company Information
- 8.4.2 SCOR SE Business Overview
- 8.4.3 SCOR SE Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.4.4 SCOR SE Life & Health Reinsurance Product Portfolio
- 8.4.5 SCOR SE Recent Developments
- 8.5 Lloyd’s
- 8.5.1 Lloyd’s Company Information
- 8.5.2 Lloyd’s Business Overview
- 8.5.3 Lloyd’s Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.5.4 Lloyd’s Life & Health Reinsurance Product Portfolio
- 8.5.5 Lloyd’s Recent Developments
- 8.6 Berkshire Hathaway
- 8.6.1 Berkshire Hathaway Company Information
- 8.6.2 Berkshire Hathaway Business Overview
- 8.6.3 Berkshire Hathaway Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.6.4 Berkshire Hathaway Life & Health Reinsurance Product Portfolio
- 8.6.5 Berkshire Hathaway Recent Developments
- 8.7 Great-West Lifeco
- 8.7.1 Great-West Lifeco Company Information
- 8.7.2 Great-West Lifeco Business Overview
- 8.7.3 Great-West Lifeco Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.7.4 Great-West Lifeco Life & Health Reinsurance Product Portfolio
- 8.7.5 Great-West Lifeco Recent Developments
- 8.8 RGA
- 8.8.1 RGA Company Information
- 8.8.2 RGA Business Overview
- 8.8.3 RGA Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.8.4 RGA Life & Health Reinsurance Product Portfolio
- 8.8.5 RGA Recent Developments
- 8.9 China RE
- 8.9.1 China RE Company Information
- 8.9.2 China RE Business Overview
- 8.9.3 China RE Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.9.4 China RE Life & Health Reinsurance Product Portfolio
- 8.9.5 China RE Recent Developments
- 8.10 Korean Re
- 8.10.1 Korean Re Company Information
- 8.10.2 Korean Re Business Overview
- 8.10.3 Korean Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.10.4 Korean Re Life & Health Reinsurance Product Portfolio
- 8.10.5 Korean Re Recent Developments
- 8.11 PartnerRe
- 8.11.1 PartnerRe Company Information
- 8.11.2 PartnerRe Business Overview
- 8.11.3 PartnerRe Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.11.4 PartnerRe Life & Health Reinsurance Product Portfolio
- 8.11.5 PartnerRe Recent Developments
- 8.12 GIC Re
- 8.12.1 GIC Re Company Information
- 8.12.2 GIC Re Business Overview
- 8.12.3 GIC Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.12.4 GIC Re Life & Health Reinsurance Product Portfolio
- 8.12.5 GIC Re Recent Developments
- 8.13 Mapfre
- 8.13.1 Mapfre Company Information
- 8.13.2 Mapfre Business Overview
- 8.13.3 Mapfre Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.13.4 Mapfre Life & Health Reinsurance Product Portfolio
- 8.13.5 Mapfre Recent Developments
- 8.14 Alleghany
- 8.14.1 Alleghany Company Information
- 8.14.2 Alleghany Business Overview
- 8.14.3 Alleghany Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.14.4 Alleghany Life & Health Reinsurance Product Portfolio
- 8.14.5 Alleghany Recent Developments
- 8.15 Everest Re
- 8.15.1 Everest Re Company Information
- 8.15.2 Everest Re Business Overview
- 8.15.3 Everest Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.15.4 Everest Re Life & Health Reinsurance Product Portfolio
- 8.15.5 Everest Re Recent Developments
- 8.16 Axa
- 8.16.1 Axa Company Information
- 8.16.2 Axa Business Overview
- 8.16.3 Axa Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.16.4 Axa Life & Health Reinsurance Product Portfolio
- 8.16.5 Axa Recent Developments
- 8.17 Canada Life Reinsurance
- 8.17.1 Canada Life Reinsurance Company Information
- 8.17.2 Canada Life Reinsurance Business Overview
- 8.17.3 Canada Life Reinsurance Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.17.4 Canada Life Reinsurance Life & Health Reinsurance Product Portfolio
- 8.17.5 Canada Life Reinsurance Recent Developments
- 8.18 Fairfax
- 8.18.1 Fairfax Company Information
- 8.18.2 Fairfax Business Overview
- 8.18.3 Fairfax Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.18.4 Fairfax Life & Health Reinsurance Product Portfolio
- 8.18.5 Fairfax Recent Developments
- 8.19 AXIS
- 8.19.1 AXIS Company Information
- 8.19.2 AXIS Business Overview
- 8.19.3 AXIS Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.19.4 AXIS Life & Health Reinsurance Product Portfolio
- 8.19.5 AXIS Recent Developments
- 8.20 CCR Re
- 8.20.1 CCR Re Company Information
- 8.20.2 CCR Re Business Overview
- 8.20.3 CCR Re Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.20.4 CCR Re Life & Health Reinsurance Product Portfolio
- 8.20.5 CCR Re Recent Developments
- 8.21 Sompo
- 8.21.1 Sompo Company Information
- 8.21.2 Sompo Business Overview
- 8.21.3 Sompo Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.21.4 Sompo Life & Health Reinsurance Product Portfolio
- 8.21.5 Sompo Recent Developments
- 8.22 The Toa Reinsurance Company
- 8.22.1 The Toa Reinsurance Company Company Information
- 8.22.2 The Toa Reinsurance Company Business Overview
- 8.22.3 The Toa Reinsurance Company Life & Health Reinsurance Revenue and Gross Margin (2021-2026)
- 8.22.4 The Toa Reinsurance Company Life & Health Reinsurance Product Portfolio
- 8.22.5 The Toa Reinsurance Company Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst